Get the Stockscreener App
5.68
2.34%
+0.13
Capricor Therapeutics Inc Stock (CAPR) Forecast
The Capricor Therapeutics Inc (CAPR) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $6.9754, representing a +22.81% increase from the current price of $5.68. The highest analyst price target is $9.7526, and the lowest is $4.1982.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CAPR Price Target
Average 7.0056
(+23.34% Upside)
Is Capricor Therapeutics Inc (CAPR) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 48.73 | Neutral |
| STOCH(9,6) | 44.52 | Neutral |
| STOCHRSI(14) | 28.91 | Neutral |
| MACD(12,26) | 0.0594 | Sell |
| ADX(14) | 13.91 | Neutral |
| William %R | -55.66 | Neutral |
| CCI(14) | -23.15 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.003
Sell
|
5.8033
Sell
|
| MA20 |
5.7095
Sell
|
5.7567
Sell
|
| MA50 |
5.8805
Sell
|
5.6377
Buy
|
| MA100 |
5.2282
Buy
|
5.3355
Buy
|
| MA200 |
4.7955
Buy
|
4.9998
Buy
|
Buy: 5
Sell: 5
Neutral: 0
Summary: Neutral
According to our latest analysis, CAPR could be considered a Neutral, with 17 technical analysis indicators signaling 5 Buy signals, 6 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on CAPR, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 48.73 indicates that CAPR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 44.52 indicates that CAPR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 28.91 indicates that CAPR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 13.91 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -23.15 indicates that CAPR is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term CAPR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Capricor Therapeutics Inc financial reports and earnings history, Capricor Therapeutics Inc (CAPR) stock could reach $6.3965 by 2030, $7.8968 by 2040 and $10.44 by 2050. See the projected annual prices until 2050 of the Capricor Therapeutics Inc stock below:
- Capricor Therapeutics Inc (CAPR) is expected to reach an average price of $5.3741 in 2035, with a high prediction of $5.7624 and a low estimate of $5.051. This indicates an $-5.39% rise from the last recorded price of $5.68.
- Capricor Therapeutics Inc (CAPR) stock is projected to chart a bullish course in 2040, with an average price target of $7.3736, representing an $29.82% surge from its current level. The forecast ranges from a conservative $7.3036 to a sky-high $7.8968.
- Our analysts predict Capricor Therapeutics Inc (CAPR) to jump 89.87% by 2045, soaring from $9.5085 to an average price of $10.78, potentially reaching $10.96. While $9.5085 is the low estimate, the potential upside is significant.
- Capricor Therapeutics Inc (CAPR) stock is expected to climb by 2050, reaching an average of $10.33, a $81.79% jump from its current level. However, a wide range of estimates exists, with high and low targets of $10.44 and $9.3055, respectively, highlighting the market's uncertainty.
Capricor Therapeutics Inc Stock (CAPR) Year by Year Forecast
Capricor Therapeutics Inc Stock (CAPR) Price Forecast for 2024
Our forecast for CAPR stock price in 2024 now indicates an average price target of $5.5158 with a high forecast of $9.7526 and a low forecast of $1.279. The average prediction reflects an decrease of -2.89% from the last recorded price of $5.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2024 | $5.3691 | $4.1982 | $9.7526 | -5.47% |
| August, 2024 | $3.6272 | $3.4972 | $5.679 | -36.14% |
| September, 2024 | $4.0302 | $3.2979 | $4.2302 | -29.05% |
| October, 2024 | $3.764 | $3.3932 | $4.8025 | -33.73% |
| November, 2024 | $3.228 | $3.017 | $3.7855 | -43.17% |
| December, 2024 | $2.3001 | $2.2801 | $3.2578 | -59.51% |
Capricor Therapeutics Inc Stock (CAPR) Price Forecast for 2025
Capricor Therapeutics Inc Stock (CAPR) is expected to reach an average price of $7.6313 in 2025, with a high prediction of $13.36 and a low estimate of $1.9037. This indicates an +34.35% rise from the last recorded price of $5.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $2.3239 | $2.0116 | $2.5108 | -59.09% |
| February, 2025 | $2.5377 | $2.2746 | $2.9861 | -55.32% |
| March, 2025 | $2.2399 | $2.1499 | $2.7277 | -60.56% |
| April, 2025 | $2.2437 | $1.9037 | $3.273 | -60.50% |
| May, 2025 | $2.6968 | $1.9846 | $2.876 | -52.52% |
| June, 2025 | $7.0198 | $3.3575 | $12.11 | +23.59% |
| July, 2025 | $6.2436 | $5.1813 | $6.9306 | +9.92% |
| August, 2025 | $5.4166 | $5.3566 | $6.2744 | -4.64% |
| September, 2025 | $7.5597 | $4.8574 | $13.36 | +33.09% |
| October, 2025 | $5.7735 | $5.2385 | $8.5304 | +1.65% |
| November, 2025 | $6.2965 | $5.3642 | $7.615 | +10.85% |
| December, 2025 | $4.9103 | $4.8803 | $6.4094 | -13.55% |
Capricor Therapeutics Inc Stock (CAPR) Price Forecast for 2026
The predicted value for Capricor Therapeutics Inc (CAPR) in 2026 is set at an average of $6.8328. Estimates vary from a peak of $9.4625 to a trough of $4.2031, indicating an +20.30% surge from the present price of $5.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $5.3434 | $4.9018 | $5.8318 | -5.93% |
| February, 2026 | $5.2564 | $5.0849 | $5.832 | -7.46% |
| March, 2026 | $6.0494 | $4.3787 | $7.0194 | +6.50% |
| April, 2026 | $8.5632 | $6.0302 | $9.4625 | +50.76% |
| May, 2026 | $6.4163 | $5.6848 | $8.7765 | +12.96% |
| June, 2026 | $5.4593 | $5.3393 | $6.517 | -3.89% |
| July, 2026 | $4.6931 | $4.2031 | $6.3716 | -17.37% |
| August, 2026 | $5.5261 | $4.6739 | $5.8461 | -2.71% |
| September, 2026 | $5.7799 | $5.3869 | $7.3017 | +1.76% |
| October, 2026 | $5.443 | $5.233 | $6.2822 | -4.17% |
| November, 2026 | $6.096 | $4.8745 | $6.236 | +7.32% |
| December, 2026 | $5.0998 | $4.9098 | $6.9391 | -10.21% |
Capricor Therapeutics Inc Stock (CAPR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Capricor Therapeutics Inc (CAPR) is $5.288, with a high forecast of $6.9118 and a low forecast of $3.6642. This indicates an -6.90% decrease from the last price of $5.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $4.9029 | $4.7113 | $5.3321 | -13.68% |
| February, 2027 | $4.4209 | $4.256 | $5.0544 | -22.17% |
| March, 2027 | $4.3897 | $3.8497 | $4.6966 | -22.72% |
| April, 2027 | $4.1927 | $3.9319 | $4.5212 | -26.18% |
| May, 2027 | $5.3458 | $3.6642 | $5.5058 | -5.88% |
| June, 2027 | $5.6896 | $5.0092 | $5.9173 | +0.17% |
| July, 2027 | $4.5426 | $4.385 | $6.9118 | -20.02% |
| August, 2027 | $4.2256 | $4.1251 | $4.9241 | -25.60% |
| September, 2027 | $4.7594 | $3.928 | $4.7872 | -16.21% |
| October, 2027 | $5.3925 | $4.4327 | $5.6225 | -5.06% |
| November, 2027 | $5.2655 | $4.5785 | $5.874 | -7.30% |
| December, 2027 | $6.1293 | $5.2252 | $6.5793 | +7.91% |
Capricor Therapeutics Inc Stock (CAPR) Price Forecast for 2028
In 2028, Capricor Therapeutics Inc (CAPR) is projected to reach an average price of $6.0818, with a high projection of $7.7169 and a low estimate of $4.4468. This indicates an +7.07% rise from the last price of $5.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $6.9723 | $5.789 | $7.1823 | +22.75% |
| February, 2028 | $7.1354 | $6.1046 | $7.3431 | +25.62% |
| March, 2028 | $6.6992 | $6.66 | $7.7169 | +17.94% |
| April, 2028 | $5.2122 | $4.9915 | $6.7399 | -8.24% |
| May, 2028 | $4.666 | $4.566 | $5.823 | -17.85% |
| June, 2028 | $5.4991 | $4.4468 | $5.6291 | -3.19% |
| July, 2028 | $5.1921 | $5.1221 | $5.8998 | -8.59% |
| August, 2028 | $5.7959 | $5.0729 | $6.3951 | +2.04% |
| September, 2028 | $5.3389 | $5.1682 | $5.9366 | -6.00% |
| October, 2028 | $5.082 | $4.862 | $5.5504 | -10.53% |
| November, 2028 | $5.7158 | $4.9527 | $6.0642 | +0.63% |
| December, 2028 | $5.9488 | $5.5804 | $6.328 | +4.73% |
Capricor Therapeutics Inc Stock (CAPR) Price Forecast for 2029
The 2029 price forecast for Capricor Therapeutics Inc Stock (CAPR) is $6.6316 on average, with a high prediction of $9.3976 and a low estimate of $3.8655. This represents an +16.75% increase from the previous price of $5.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.5726 | $5.4196 | $6.0194 | -1.89% |
| February, 2029 | $8.9456 | $5.5235 | $9.2856 | +57.49% |
| March, 2029 | $7.4387 | $7.0364 | $9.3976 | +30.96% |
| April, 2029 | $4.0417 | $3.9317 | $7.7294 | -28.84% |
| May, 2029 | $3.9855 | $3.8655 | $4.1125 | -29.83% |
| June, 2029 | $4.1485 | $3.9063 | $4.5762 | -26.96% |
| July, 2029 | $6.0816 | $4.1793 | $6.3646 | +7.07% |
| August, 2029 | $5.2354 | $5.0739 | $6.6723 | -7.83% |
| September, 2029 | $5.1084 | $4.7577 | $5.3661 | -10.06% |
| October, 2029 | $7.5822 | $5.0692 | $8.4222 | +33.49% |
| November, 2029 | $6.2153 | $5.8903 | $8.4837 | +9.42% |
| December, 2029 | $6.315 | $5.906 | $6.8888 | +11.18% |
Capricor Therapeutics Inc Stock (CAPR) Price Forecast for 2030
Capricor Therapeutics Inc Stock (CAPR) is expected to reach an average price of $6.5061 in 2030, with a high forecast of $10.75 and a low forecast of $2.2671. This signifies an +14.54% surge from the last price of $5.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.4797 | $2.2671 | $6.3965 | -3.53% |
| February, 2030 | $5.2137 | $4.9291 | $5.9122 | -8.21% |
| March, 2030 | $5.8297 | $5.7597 | $10.75 | +2.64% |
| April, 2030 | $4.4058 | $4.2958 | $5.9113 | -22.43% |
| May, 2030 | $5.5985 | $4.3073 | $5.6334 | -1.43% |
| June, 2030 | $4.7595 | $4.3965 | $5.8049 | -16.21% |
| July, 2030 | $3.7921 | $3.7241 | $4.791 | -33.24% |
| August, 2030 | $3.0932 | $3.0232 | $3.8786 | -45.54% |
| September, 2030 | $3.7192 | $3.0647 | $3.8742 | -34.52% |
| October, 2030 | $3.4168 | $3.3868 | $4.0023 | -39.84% |
| November, 2030 | $3.1129 | $2.9251 | $3.4884 | -45.20% |
| December, 2030 | $3.0591 | $3.0091 | $4.296 | -46.14% |
0.79%
3.50%
Cap:
|
Volume (24h):